Crossopteryx febrifuga
Crossopteryx febrifuga · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Crossopteryx febrifuga is a medicinal plant valued for its significant antibacterial, antimalarial, and spasmolytic activities. Various parts of the plant, specifically the leaves, fruits, and seeds, are utilized in traditional treatments. Practitioners often prepare aqueous leaf extracts or decoctions to harness its therapeutic potential. These preparations are commonly used to combat conditions such as malaria, trypanosomiasis, and various infectious skin diseases. Through the use of its leaves and seeds, this species remains a vital resource in managing diverse parasitic and bacterial ailments.
- Synonyms
- Crossopteryx Africana · Crossopteryx Kotschyana · 6 more
- Common names
- Not available
- Family
- Rubiaceae
- Distribution
- Southern America
- Plant Parts
- Leaf · Fruit
Classification
Common Names
Crossopteryx febrifuga is a versatile plant known by a diverse array of names across different regions. It is frequently referred to as African-Bark or Crystalbark, highlighting its distinctive physical characteristics. In certain botanical circles, it may also be identified as Febrifugal Rondeletia. Local traditions contribute to its linguistic variety, with names such as Fititonga and Mukomberwa being commonly used. This wide range of nomenclature reflects the deep cultural and regional importance of the species.
Sources: Catalogue of Life (COL)
Synonyms
Crossopteryx febrifuga is a botanical species characterized by a complex network of taxonomic synonyms. Scientific literature identifies this plant under various names, including the historical classifications of Chomelia angolensis and Chomelia buchananii. It is also frequently associated with the synonyms Chomelia mossambicensis and Crossopteryx africana. Furthermore, the designation Crossopteryx kotschyana is recognized as another valid synonym within its botanical history. Understanding these overlapping relationships is essential for accurate identification and research within the genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Crossopteryx febrifuga is a distinct biological entity that belongs to the vast kingdom Plantae. Within this expansive group, it is specifically classified under the class Equisetopsida. This species is further defined by its placement in the order Gentianales, showcasing its evolutionary lineage. It also shares a close taxonomic connection with other members of the family Rubiaceae. Ultimately, this plant is identified by its unique genus, Crossopteryx.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Crossopteryx |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Crossopteryx febrifuga is a plant species with a notable presence across several regions of the African continent. It is widely distributed throughout East Tropical Africa, where it can be found in Kenya, Tanzania, and Uganda. Beyond the eastern regions, the species also extends into Northeast Tropical Africa. Specifically, its range includes the diverse landscapes of both Chad and Ethiopia. This wide geographic reach highlights the plant's adaptability to different tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Crossopteryx febrifuga is a self-supporting plant that grows in the form of a tree. This species exhibits significant variability in its stature, with individual specimens reaching a minimum height of only 1.8 meters. However, many mature trees grow much larger, frequently surpassing a height of 6.33 meters. Ultimately, these trees can reach a maximum height of up to 15 meters. Such diverse growth patterns allow the species to establish a strong presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Crossopteryx febrifuga is a versatile medicinal plant recognized for its diverse therapeutic properties. Research indicates that leaf extracts of this species can be used to synthesize silver nanoparticles that exhibit significant antibacterial activity against human skin pathogens. Furthermore, ethnobotanical surveys highlight its frequent use by traditional healers in Guinea as a remedy for treating malaria. The plant also demonstrates notable spasmolytic activity, which is particularly effective in inhibiting intestinal contractions. These combined biological attributes underscore the potential importance of this species in managing various infectious and gastrointestinal conditions.
Compounds
Conditions
Crossopteryx febrifuga demonstrates significant medicinal potential by inhibiting the growth of Entamoeba histolytica through its polyphenolic fractions. The plant also exhibits antiplasmodial activity against the Plasmodium falciparum chloroquine-resistant W2 strain. In terms of spasmolytic effects, it effectively treats contractions induced by acetylcholine and/or KCl solutions in isolated guinea-pig ileum. Its respiratory benefits include the protection of sensitized guinea-pigs against antigen-induced bronchospasm. Additionally, the plant serves to decrease the frequency of citric acid-induced coughs in experimental models.
Preparations
Crossopteryx febrifuga is prepared as a decoction for treating fever and respiratory diseases in Mali. The plant is also utilized in the form of aqueous leaf extracts to facilitate the green synthesis of antimicrobial silver nanoparticles. In various traditional medicinal contexts, the leaves are used directly or prepared as specific decoctions. Additionally, the seeds of the plant are investigated for their antioxidant and 15-lipoxygenase inhibitory activities. Finally, water and water-ethanol soluble polysaccharide materials are isolated from the fruits of Crossopteryx febrifuga for study.
Parts used
Crossopteryx febrifuga is a medicinal plant species that offers various biological benefits through its different anatomical parts. Research has demonstrated that aqueous leaf extracts from this plant can be utilized for the green synthesis of silver nanoparticles with potent antibacterial properties. Additionally, the fruit of the species contains pectic type polysaccharides that have been investigated for their potential effects on airway reactivity. Studies focusing on the seeds of the plant have also revealed significant antioxidant and 15-lipoxygenase inhibitory activities. Together, these findings highlight how the leaves, fruits, and seeds of Crossopteryx febrifuga contribute to its diverse therapeutic potential.